Correction: 3D-printed electrochemical cells for multi-point aptamer-based drug measurements

TL;DR

This paper corrects an earlier study on 3D-printed electrochemical cells used for measuring drugs with aptamers.

Contribution

The paper provides a correction to previously published research findings and methodology.

Findings

Errors in the original study's methodology were identified and addressed.

Revisions were made to ensure the accuracy of the drug measurement results.

Abstract

Correction for ‘3D-printed electrochemical cells for multi-point aptamer-based drug measurements’ by John Mack et al., Sens. Diagn., 2024, 3, 1533–1541, https://doi.org/10.1039/D4SD00192C.

Full text

We, the authors of the manuscript noted above, have identified an error in the text of the article. In Table 1, the DNA sequence for the tobramycin aptamer was mistakenly reported as 5′-GGC GAC AAG GAA AAT CCT TCA ACG AAG GTG GGT GGC C-3′.

The correct sequence for the tobramycin aptamer is given in the corrected Table 1 shown below, maintaining the original citation.

We apologize for this error, which occurred because of a copy-paste mistake during finalizing the manuscript draft. This mistake does not impact the significance, interpretation, or conclusion of the results of this study. However, we believe it important to clarify for the sake of transparency and repeatability.

The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.